Introduction: Outcomes in metastatic colorectal cancer are improving, with better
understanding and use of targeted therapies. Areas covered: A review of the literature and …

BACKGROUND Previous reports have described differences in biology and outcome for
colorectal cancer based on whether the primary is right or left sided. Further division by right …

International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and
Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct - PMC Back …

Background To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of
eftilagimod alpha (efti), a soluble lymphocyte activation gene-3 protein, in combination with …

Introduction Colorectal cancer is a heterogenous disease, with various clinical and
molecular subtypes related to the primary site (left versus right colon) of the original tumor …

In this experimental study on a laboratory-scale turbulent annular combustor with sixteen
swirl-stabilized burners, we study the flame-flame and flame-acoustic interactions during …

Background Colorectal cancer (CRC) is a common malignancy. There is growing evidence
that CRC incidence is increasing in the younger population. There is controversy …

Purpose Women with advanced breast cancer (ABC) face significant adjustment challenges,
yet few resources provide them with information and support, and attendance barriers can …

Purpose Methylation in IKZF1 and BCAT1 are common events in colorectal cancer (CRC).
They are often detected in blood as circulating tumor DNA (ctDNA) at diagnosis and …

Cancers of the upper gastrointestinal tract are a leading cause of cancer-related death world-
wide and historically have a poor prognosis. The incidence and histology of these cancers …